Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
-
AstraZeneca to invest £11.5 million in new clinical oncology bioinformatics collaboration with The University of Manchester
-
AstraZeneca to update on leading lung cancer portfolio at WCLC 2015
-
US FDA approves expanded indication for BRILINTA to include long-term use in patients with a history of heart attack
-
AstraZeneca enters license agreement with Daiichi Sankyo for development and commercialisation of FluMist in Japan
-
Positive Phase III results demonstrate efficacy of antibiotic medicine CAZ-AVI in complicated Urinary Tract Infections
-
AstraZeneca and Valeant Pharmaceuticals to partner on brodalumab
-
PEGASUS-TIMI 54 sub-analysis shows importance of continuing treatment with BRILINTA beyond one year following a heart attack
-
AstraZeneca to present further research into long-term prevention of cardiovascular events for patients with a history of heart attack at ESC Congress 2015
-
AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer
Latest articles and press releases
All of our latest press releases and articles are available to explore
